Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Women's health
Pharma
Iterum nabs FDA approval for oral UTI drug after prior rejection
Despite recent concerns from the FDA about potential off-label use, Iterum has scored a green light for its oral antibiotic sulopenem.
Fraiser Kansteiner
Oct 25, 2024 2:52pm
Organon pays up to $1.2B to acquire Dermavant and its drug Vtama
Sep 18, 2024 10:09am
Organon to assume Emgality marketing duties in 11 new countries
Aug 20, 2024 10:50am
Hologic survey uncovers 'Screening Action Gap' in women’s health
Jul 9, 2024 12:18pm
Industry commends Supreme Court's mifepristone ruling
Jun 14, 2024 2:42pm
EU regulator calls for withdrawal of certain preterm birth drugs
May 17, 2024 10:37am
